Corbus Pharmaceuticals Holdings, Inc. (0SZI.L) LSE
7.53
+0.25428(+3.49%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 108.53M |
| Enterprise Value | 81.01M |
| P/E Ratio | -1.19 |
| PEG Ratio | 0.12 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.79 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.81 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
Management Effectiveness
| Return On Assets | -0.59 |
| Return On Equity | -0.71 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -233,000 |
| EBITDA | -85.08M |
| Net Income | -78.54M |
| Diluted EPS | -5.9 |
Balance Sheet
| Total Cash | 138.6M |
| Total Cash/Share | 10.41 |
| Total Debt | 1.21M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 7.92 |
| Book Value Per Share | 9.49 |
Price History
| 52-Week Change | -6.22 |
| 52-Week High | 49.65 |
| 52-Week Low | 2.82 |
| Moving Average 50 Days | 21.54 |
| Moving Average 200 Days | 10.76 |
Statistics
| Average Volume | 3,322 |
| Shares Outstanding | 12.54M |
| % Held by Institutions | 77.83 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 33333:1000000 |
| Last Split Date | February 14, 2023 |
